HD9994.C6
|
Erfolgreicher Markteintritt in China für den deutschen Mittelstand (KMU). Am Beispiel der deutschen Medizintechnik. |
1 |
HD9994 .C62 1994
|
Innovating for health : the story of Baxter International / |
1 |
HD9994.U52 W45 2011eb
|
Cost-contained regulatory compliance : for the pharmaceutical, biologics, and medical device industries / |
1 |
HD9994.U54 B393 1990
|
Strategy of a megamerger : an insider's account of the Baxter Travenol-American Hospital Supply combination / |
1 |
HD9995.C62 M56 1985
|
At any cost : corporate greed, women, and the Dalkon Shield / |
1 |
HD9995.C64 A2343 1997
|
Unshielded : the human cost of the Dalkon Shield / |
1 |
HD9995.C64 A236 1985
|
Nightmare : women and the Dalkon Shield / |
1 |
HD9995.H423 U627 2018
|
Bad blood : secrets and lies in a Silicon Valley startup / |
1 |
HD9995.H562 ǂb T46 2009eb
|
Beyond the Gift Shop : Boost Revenue, Your Brand, and Patient Satisfaction with Strategic Hospital Retail. |
1 |
HD9995.S24 K564 2004
|
Kotex, Kleenex, Huggies : Kimberly-Clark and the consumer revolution in American business / |
1 |
HD9999
|
The Handbook of Managing and Marketing Tourism Experiences. |
1 |
HD9999.A23 T95 1960
|
The Norton story / |
1 |
HD9999.B163 N47 2008ev
|
Gra Pala Ge / |
1 |
HD9999.B44 HD9999.B442 B542 2005 HD9999.B442B542 2005 HD9999.B442
|
BioIndustry Ethics. |
1 |
HD9999.B442
|
Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes / Managing biotechnology : from science to market in the digital age / |
2 |
HD9999.B442 .A978 2016
|
Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries : the Commercialization of Intellectual Property. |
1 |
HD9999.B442 B47 2004eb
|
Biotech industry : a global, economic, and financing overview / |
1 |
HD9999.B442 B64 2008eb
|
Valuation in life sciences : a practical guide / |
1 |
HD9999.B442 B87 1991
|
Plants, power, and profit : social, economic, and ethical consequences of the new biotechnologies / |
1 |
HD9999.B442 C663 2014
|
International Strategy and Market Performance in New Biotechnology Firms. |
1 |